Ledger.Open graph →
SEC Form D · Amendment · filed May 6, 2016

Acer Therapeutics Inc

Offering
$8.1M
Sold
$8.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John Dunn · Cambridge, MADirectorStephen Aselage · Cambridge, MADirectorChristopher S. Schelling · Cambridge, MAExec · Director · PromoterLuc Marengere · Cambridge, MADirectorHarry S. Palmin · Cambridge, MAPromoterCynthia S. Lavoie · Cambridge, MADirectorShaka Kariuki · New York, NYPromoterCheryl Baker · Jupiter, FLDirectorHector Negroni · New York, NYDirectorIndraneel Das · Tampa, FLDirectorKamal Pallan · New York, NYExec · Director · PromoterBrad Tank · Chicago, ILDirectorGrant J. Asay · Waltham, MADirectorRoger H. Hanson · Grand Cayman, Cayman IslandsPromoterBrian H. Eden · Grand Cayman, Cayman IslandsExec · Director · PromoterPeter Solvik · San Diego, CADirectorBill Ruh · San Diego, CADirectorJon Carder · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗